Janux Therapeutics (JANX) PT Lowered to $23 at Evercore ISI
Tweet
Share
E-mailGet Alerts JANX Hot Sheet
Price: $14.58 --0%
Rating Summary:
14 Buy, 4 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 17 | New: 18
Rating Summary:
14 Buy, 4 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 17 | New: 18
Join SI Premium – FREE
Evercore ISI analyst Jonathan Miller lowered the price target on Janux Therapeutics (NASDAQ: JANX) to $23.00 (from $25.00) while maintaining a Outperform rating.
You May Also Be Interested In
- CoreCivic (CXW) PT Raised to $36 at Benchmark
- CG Power & Industrial Solutions (CGPOWER:IN) PT Raised to INR1,100 at Nomura/Instinet
- JPMorgan Upgrades Cathay Financial Holding Co (2882:TT) to Overweight
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
